Adam A. Friedman

774 total citations
6 papers, 506 citations indexed

About

Adam A. Friedman is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Adam A. Friedman has authored 6 papers receiving a total of 506 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Oncology and 1 paper in Pathology and Forensic Medicine. Recurrent topics in Adam A. Friedman's work include Melanoma and MAPK Pathways (4 papers), CAR-T cell therapy research (2 papers) and Cytokine Signaling Pathways and Interactions (1 paper). Adam A. Friedman is often cited by papers focused on Melanoma and MAPK Pathways (4 papers), CAR-T cell therapy research (2 papers) and Cytokine Signaling Pathways and Interactions (1 paper). Adam A. Friedman collaborates with scholars based in United States. Adam A. Friedman's co-authors include David E. Fisher, Keith T. Flaherty, Anthony Letai, Svetlana Pacifico, Arunachalam Vinayagam, Dong Yan, Bonnie Berger, Xiaoyun Sun, Russell L. Finley and Richard Binari and has published in prestigious journals such as Nature reviews. Cancer, PLoS ONE and Clinical Cancer Research.

In The Last Decade

Adam A. Friedman

6 papers receiving 498 citations

Peers

Adam A. Friedman
Hayley E. Francies United Kingdom
Shannon Decker United States
Jordan F. Hastings Australia
Ann Palladino United States
Tim Hammonds United Kingdom
Nataly Kravchenko‐Balasha Israel
Swapnil Potdar Finland
Alexander R. Chait United States
Michela Cortesi Italy
Philippe Lucarelli Luxembourg
Hayley E. Francies United Kingdom
Adam A. Friedman
Citations per year, relative to Adam A. Friedman Adam A. Friedman (= 1×) peers Hayley E. Francies

Countries citing papers authored by Adam A. Friedman

Since Specialization
Citations

This map shows the geographic impact of Adam A. Friedman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam A. Friedman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam A. Friedman more than expected).

Fields of papers citing papers by Adam A. Friedman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adam A. Friedman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam A. Friedman. The network helps show where Adam A. Friedman may publish in the future.

Co-authorship network of co-authors of Adam A. Friedman

This figure shows the co-authorship network connecting the top 25 collaborators of Adam A. Friedman. A scholar is included among the top collaborators of Adam A. Friedman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adam A. Friedman. Adam A. Friedman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Friedman, Adam A., Yun Xia, Lorenzo Trippa, et al.. (2017). Feasibility of Ultra-High-Throughput Functional Screening of Melanoma Biopsies for Discovery of Novel Cancer Drug Combinations. Clinical Cancer Research. 23(16). 4680–4692. 5 indexed citations
2.
Friedman, Adam A., Anthony Letai, David E. Fisher, & Keith T. Flaherty. (2015). Precision medicine for cancer with next-generation functional diagnostics. Nature reviews. Cancer. 15(12). 747–756. 397 indexed citations
3.
Friedman, Adam A., Arnaud Amzallag, Iulian Pruteanu-Malinici, et al.. (2015). Landscape of Targeted Anti-Cancer Drug Synergies in Melanoma Identifies a Novel BRAF-VEGFR/PDGFR Combination Treatment. PLoS ONE. 10(10). e0140310–e0140310. 31 indexed citations
4.
Friedman, Adam A. & Keith T. Flaherty. (2013). Scratching the combinatorial drug landscape surface. Pigment Cell & Melanoma Research. 26(3). 297–299. 1 indexed citations
5.
Friedman, Adam A., George Tucker, Rohit Singh, et al.. (2011). Proteomic and Functional Genomic Landscape of Receptor Tyrosine Kinase and Ras to Extracellular Signal–Regulated Kinase Signaling. Science Signaling. 4(196). rs10–rs10. 71 indexed citations
6.
Friedman, Adam A.. (1998). A Review of Highly Conserved PAX6 Gene in Eye Development Regulation. Biochemistry and Molecular Biology Education. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hayley E. Francies Breakdown of academic impact, for papers by Shannon Decker Breakdown of academic impact, for papers by Jordan F. Hastings Breakdown of academic impact, for papers by Ann Palladino Breakdown of academic impact, for papers by Tim Hammonds Breakdown of academic impact, for papers by Nataly Kravchenko‐Balasha Breakdown of academic impact, for papers by Swapnil Potdar Breakdown of academic impact, for papers by Alexander R. Chait Breakdown of academic impact, for papers by Michela Cortesi Breakdown of academic impact, for papers by Philippe Lucarelli
Rankless by CCL
2026